Nanoform appoints Miguel Calado as Chairman of the Board
Helsinki, Finland – Nanoform, an innovative nanoparticle medicine enabling company, has appointed Miguel Calado as Chairman of the Board. Following a one-year succession process, Miguel will succeed Rabbe Klemets, who is moving into an advisory position. Non-executive board member, Mads Laustsen, will assume Miguel’s previous role of Vice Chairman. Since joining Nanoform’s board last year as Vice Chairman, Miguel has applied his expertise in strategic business management and finance to contribute to the company’s recent success within international markets. Miguel previously was CFO at